Track papers across labs, topics, and trends.
Search papers, labs, and topics across Lattice.
1
0
0
18
Investigating patients with unresectable advanced or recurrent esophageal cancer or Siewert type I esophagogastric junction cancer who initiated first-line immunochemotherapy at Shizuoka Cancer Center between December 2021 and December 2025 suggests the potential to expand the indication for immunochemotherapy in real-world clinical practice.